
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
The latest updates in geriatric psychiatry.
Dr Lavretsky discusses her thoughts on the state of geriatric psychiatry from the APA Annual Meeting. She is Professor of Psychiatry at UCLA. She also directs the Late Life Mood, Stress, and Wellness Research Program at the Semel Institute at UCLA. She is an editorial board member of Psychiatric Times.
Further reading:




